BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 36736432)

  • 1. Fingolimod promotes blood-nerve barrier properties in vitro.
    Nishihara H; Maeda T; Sano Y; Ueno M; Okamoto N; Takeshita Y; Shimizu F; Koga M; Kanda T
    Brain Behav; 2018 Apr; 8(4):e00924. PubMed ID: 29670818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.
    Mahmoudi K; Bouras A; Bozec D; Ivkov R; Hadjipanayis C
    Int J Hyperthermia; 2018 Dec; 34(8):1316-1328. PubMed ID: 29353516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their Nanodrugs.
    Wang X; Hao X; Zhang Y; Wu Q; Zhou J; Cheng Z; Chen J; Liu S; Pan J; Wang Y; Fan JB
    Adv Mater; 2024 May; ():e2405165. PubMed ID: 38758975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.
    Busquets MA; Espargaró A; Sabaté R; Estelrich J
    Nanomaterials (Basel); 2015 Dec; 5(4):2231-2248. PubMed ID: 28347118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function.
    Weigel C; Bellaci J; Spiegel S
    J Biol Chem; 2023 Jun; 299(6):104775. PubMed ID: 37142226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments in Magnetic Hyperthermia Therapy (MHT) and Magnetic Particle Imaging (MPI) in the Brain Tumor Field: A Scoping Review and Meta-Analysis.
    Rentzeperis F; Rivera D; Zhang JY; Brown C; Young T; Rodriguez B; Schupper A; Price G; Gomberg J; Williams T; Bouras A; Hadjipanayis C
    Micromachines (Basel); 2024 Apr; 15(5):. PubMed ID: 38793132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endocytosis rate and enhanced lysosomal pathway of silica-coated superparamagnetic nanoparticles into M-HeLa cells compared with cultured primary motor neurons.
    Sibgatullina G; Ramazanova I; Salnikov V; Stepanov A; Voloshina A; Sapunova A; Mustafina A; Petrov K; Samigullin D
    Histochem Cell Biol; 2024 Jun; 161(6):507-519. PubMed ID: 38597938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Paramagnetic Metal-Organic Framework Enhances Mild Magnetic Hyperthermia Therapy by Downregulating Heat Shock Proteins and Promoting Ferroptosis via Aggravation of Two-Way Regulated Redox Dyshomeostasis.
    Wang Y; Chen Z; Li J; Wen Y; Li J; Lv Y; Pei Z; Pei Y
    Adv Sci (Weinh); 2024 Mar; 11(11):e2306178. PubMed ID: 38161219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Brain Tumor Therapy Based on the Magnetic Nanoparticles.
    Xu S; Zhang G; Zhang J; Liu W; Wang Y; Fu X
    Int J Nanomedicine; 2023; 18():7803-7823. PubMed ID: 38144513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.
    Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H
    J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors.
    Liu Y; Wang X; Li J; Tang J; Li B; Zhang Y; Gu N; Yang F
    Adv Mater; 2021 Jul; 33(30):e2101701. PubMed ID: 34106489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer.
    Wu H; Liu L; Ma M; Zhang Y
    J Control Release; 2023 Mar; 355():248-258. PubMed ID: 36736432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate signaling at the blood-brain barrier.
    Prager B; Spampinato SF; Ransohoff RM
    Trends Mol Med; 2015 Jun; 21(6):354-63. PubMed ID: 25939882
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.